I wonder if negotiations aren't just about LymPro
Post# of 30028
Posted On: 08/28/2014 12:56:45 PM
I wonder if negotiations aren't just about LymPro .
"potential ‘spin-out’ of our diagnostics division (which includes LymPro and NuroPro)"
http://www.thechairmansblog.com/amarantus-bio...auShB.dpuf
A question to anyone that has had conversations with GC this year. Does anyone know if there is any talk, progress or advancement with PhenoGuard, either science wise or partnering wise?
JC
"we believe we will be able to find the appropriate partner for PhenoGuard to fully exploit the true value of this technology."
"We expect to be in a position to start collaborating on this project in early 2014 having expanded our PhenoGuard cell line library to 88 cell lines from four distinct brain regions associated with Parkinson’s, Alzheimer’s, Clinical Depression and Huntington’s disease."
http://www.thechairmansblog.com/amarantus-bio...n6zL4.dpuf
"potential ‘spin-out’ of our diagnostics division (which includes LymPro and NuroPro)"
http://www.thechairmansblog.com/amarantus-bio...auShB.dpuf
A question to anyone that has had conversations with GC this year. Does anyone know if there is any talk, progress or advancement with PhenoGuard, either science wise or partnering wise?
JC
"we believe we will be able to find the appropriate partner for PhenoGuard to fully exploit the true value of this technology."
"We expect to be in a position to start collaborating on this project in early 2014 having expanded our PhenoGuard cell line library to 88 cell lines from four distinct brain regions associated with Parkinson’s, Alzheimer’s, Clinical Depression and Huntington’s disease."
http://www.thechairmansblog.com/amarantus-bio...n6zL4.dpuf
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼